Total Payments
$6,387
2024 Payments
$831.64
Companies
50
Transactions
259
Medicare Patients
999
Medicare Billing
$101,847
Payment Breakdown by Category
Food & Beverage$5,787 (90.6%)
Consulting$500.00 (7.8%)
Education$99.54 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,787 | 253 | 90.6% |
| Consulting Fee | $500.00 | 1 | 7.8% |
| Education | $99.54 | 5 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $923.82 | 20 | $0 (2024) |
| Kowa Pharmaceuticals America, Inc. | $863.96 | 9 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $807.14 | 16 | $0 (2023) |
| Lilly USA, LLC | $393.96 | 25 | $0 (2024) |
| Novo Nordisk Inc | $337.65 | 16 | $0 (2024) |
| ABBVIE INC. | $312.92 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $267.99 | 19 | $0 (2022) |
| GlaxoSmithKline, LLC. | $233.98 | 14 | $0 (2024) |
| Merck Sharp & Dohme LLC | $189.84 | 14 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $156.92 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $831.64 | 43 | Lilly USA, LLC ($161.95) |
| 2023 | $1,483 | 43 | Kowa Pharmaceuticals America, Inc. ($500.00) |
| 2022 | $631.39 | 26 | Amgen Inc. ($132.42) |
| 2021 | $30.97 | 1 | Kowa Pharmaceuticals America, Inc. ($30.97) |
| 2020 | $132.44 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($39.64) |
| 2019 | $1,382 | 50 | SANOFI-AVENTIS U.S. LLC ($340.53) |
| 2018 | $1,140 | 43 | SANOFI-AVENTIS U.S. LLC ($362.23) |
| 2017 | $755.34 | 45 | Amgen Inc. ($155.48) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $20.81 | General |
| Category: Cranial Orthotic | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: VACCINES | ||||||
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: VACCINES | ||||||
| 10/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Endocrinology | ||||||
| 10/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Cardio-renal | ||||||
| 08/13/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: VACCINES | ||||||
| 08/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROLOGY | ||||||
| 07/30/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: RESPIRATORY | ||||||
| 07/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Cardio-renal | ||||||
| 07/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Oncology | ||||||
| 07/03/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: PSYCHIATRY | ||||||
| 06/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROSCIENCE | ||||||
| 06/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Gastroenterology | ||||||
| 06/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.61 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Inflammation | ||||||
| 05/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.24 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes | ||||||
| 05/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.46 | General |
| 05/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 56 | 124 | $21,882 | $9,596 |
| 2022 | 3 | 67 | 164 | $25,045 | $11,492 |
| 2021 | 13 | 354 | 637 | $93,406 | $34,394 |
| 2020 | 14 | 522 | 847 | $130,864 | $46,364 |
Total Patients
999
Total Services
1,772
Medicare Billing
$101,847
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 97 | $19,792 | $8,565 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 14 | $1,986 | $929.28 | 46.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 13 | $104.00 | $101.92 | 98.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 102 | $20,604 | $9,526 | 46.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 15 | $4,065 | $1,827 | 44.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 24 | 47 | $376.00 | $139.44 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 167 | $31,730 | $9,223 | 29.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 37 | 121 | $22,627 | $8,445 | 37.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 18 | 46 | $8,602 | $3,308 | 38.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 21 | 21 | $4,137 | $2,847 | 68.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 19 | 19 | $6,479 | $2,502 | 38.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 17 | 25 | $6,350 | $2,118 | 33.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 47 | $6,110 | $1,940 | 31.7% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 12 | 12 | $3,336 | $1,307 | 39.2% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 13 | 14 | $966.00 | $909.36 | 94.1% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 11 | 11 | $451.00 | $414.85 | 92.0% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 11 | 12 | $492.00 | $398.12 | 80.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 18 | 18 | $540.00 | $348.12 | 64.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 57 | 106 | $848.00 | $318.00 | 37.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 18 | $738.00 | $315.15 | 42.7% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2020 | 88 | 206 | $38,522 | $15,313 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 73 | 174 | $32,766 | $8,734 | 26.7% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2020 | 33 | 37 | $10,286 | $4,057 | 39.4% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 23 | 23 | $7,843 | $3,137 | 40.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 25 | 25 | $6,650 | $2,645 | 39.8% |
About Dr. Chima Nwizu, MD
Dr. Chima Nwizu, MD is a Family Medicine healthcare provider based in Greeley, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1902882517.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chima Nwizu, MD has received a total of $6,387 in payments from pharmaceutical and medical device companies, with $831.64 received in 2024. These payments were reported across 259 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($5,787).
As a Medicare-enrolled provider, Nwizu has provided services to 999 Medicare beneficiaries, totaling 1,772 services with total Medicare billing of $101,847. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Greeley, CO
- Active Since 12/16/2005
- Last Updated 04/01/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1902882517
Products in Payments
- Repatha (Biological) $734.11
- VRAYLAR (Drug) $342.41
- Livalo (Drug) $310.98
- DISEASE STATE (Drug) $233.70
- FARXIGA (Drug) $181.18
- JARDIANCE (Drug) $178.45
- Kerendia (Drug) $153.62
- HYPERLIPIDEMIA - DISEASE (Drug) $140.39
- TOUJEO (Drug) $137.00
- LONHALA MAGNAIR (Drug) $134.60
- TRULICITY (Drug) $127.16
- Ozempic (Drug) $121.60
- MOUNJARO (Drug) $119.46
- JANUVIA (Drug) $109.38
- NURTEC ODT (Drug) $104.12
- LEQVIO (Drug) $104.01
- Cologuard Collection Kit (Device) $95.15
- DIABETES - DISEASE (Drug) $93.01
- PRALUENT (Biological) $92.24
- PRALUENT (Drug) $88.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Greeley
Joy Ruff, M.d, M.D
Family Medicine — Payments: $44,700
Family Medicine $44,700
Dr. Gregory Denzel, Do, DO
Family Medicine — Payments: $5,085
Family Medicine $5,085
Dr. Donald Wilson, Md, MD
Family Medicine — Payments: $4,831
Family Medicine $4,831
Dr. Robert Haskins, Md, MD
Family Medicine — Payments: $3,179
Family Medicine $3,179
Kyle Waugh, Md, MD
Family Medicine — Payments: $3,127
Family Medicine $3,127
Erin Morley, M.d, M.D
Family Medicine — Payments: $2,848
Family Medicine $2,848